Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Aleksa · SciRah

Researcher profile · Semantic Scholar

A. Aleksa

Share profile

A. Aleksa — researcher profile on SciRah

h-index: 11
Works: 16
Citations: 881

Most-cited papers

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study
S. Borisov, K. Dheda, M. Enwerem, Rodolfo Romero Leyet +60 more
2017European Respiratory Journal281 citations Open access
Semantic Scholar
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
S. Borisov, E. Danila, A. Maryandyshev, M. Dalcolmo +84 more
2019European Respiratory Journal158 citations Open access
Semantic Scholar
Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB
Simon Tiberi, G. Sotgiu, L. D'Ambrosio, R. Centis +36 more
2016European Respiratory Journal80 citations Open access
Semantic Scholar
Faster for less: the new “shorter” regimen for multidrug-resistant tuberculosis
G. Sotgiu, Simon Tiberi, L. D'Ambrosio, R. Centis +17 more
2016European Respiratory Journal76 citations Open access
Semantic Scholar
Clinical standards for the dosing and management of TB drugs
J. Alffenaar, S. Stocker, L. D. Forsman, A. Garcia-Prats +47 more
2022The International Journal of Tuberculosis and Lung Disease64 citations Open access
Semantic Scholar
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study.
O. Akkerman, A. Aleksa, J. Alffenaar, Nada Almarzouqi +76 more
2019International Journal of Infectious Diseases52 citations Open access
Semantic Scholar
Clinical standards for the management of adverse effects during treatment for TB
K. P. Singh, A. Carvalho, R. Centis, L. D. Ambrosio +61 more
2023The International Journal of Tuberculosis and Lung Disease49 citations Open access
Semantic Scholar
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort.
S. Koirala, S. Borisov, E. Danila, A. Mariandyshev +94 more
2021Pulmonology48 citations Open access
Semantic Scholar
Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis.
Simon Tiberi, G. Sotgiu, L. D'Ambrosio, R. Centis +36 more
2016Clinical Infectious Diseases35 citations Open access
Semantic Scholar
Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis
Anne-Fleur Louise Van der Paardt, O. Akkerman, G. Gualano, F. Palmieri +11 more
2017European Respiratory Journal17 citations Open access
Semantic Scholar
Quality Assessment of Dried Blood Spots from Tuberculosis Patients from Four Countries.
M. A. Zuur, Herman Veenhof, A. Aleksa, N. van 't Boveneind-Vrubleuskaya +14 more
2019Therapeutic Drug Monitoring16 citations Open access
Semantic Scholar
Bedaquiline (BQ)-containing regimen at the programmatic level for MDR-TB: preliminary results
S. Borisov, K. Dheda, M. Enwerem, Rodolfo Romero Leyet +59 more
20174 citations
Semantic Scholar
Effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of multidrug resistant tuberculosis
Simon Tiberi, G. Sotgiu, L. D'Ambrosio, R. Centis +35 more
20163 citations
Semantic Scholar
Adverse effects of chemotherapy in patients with multidrug-resistant tuberculosis with alcohol abuse and without one
A. Aleksa, I. Gelberg, Siargej Wolf, Janina Artsukevich +3 more
2018Tuberculosis0 citations
Semantic Scholar
Cost-utility analysis of high-dose treatment for intermediate-susceptible, dose-dependent tuberculosis patients.
M. A. Zuur, A. V. van Asselt, N. van 't Boveneind-Vrubleuskaya, A. Aleksa +2 more
2018The International Journal of Tuberculosis and Lung Disease0 citations Open access
Semantic Scholar
Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of multidrug-resistant tuberculosis
M. Payen, Simon Tiberi, G. Sotgiu, L. D'Ambrosio +36 more
20160 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Simon Tiberi×13
Invite
Simon Tiberi — researcher profile on SciRah
A. Skrahina×13
Invite
A. Skrahina — researcher profile on SciRah
R. Centis×12
Invite
R. Centis — researcher profile on SciRah
O. Akkerman×12
Invite
O. Akkerman — researcher profile on SciRah

×11

Invite

G. Gualano — researcher profile on SciRah

G. Migliori×11

Invite

G. Migliori — researcher profile on SciRah

L. D'Ambrosio×10

Invite

L. D'Ambrosio — researcher profile on SciRah

Invite

G. Sotgiu — researcher profile on SciRah

J. Caminero×10

Invite

J. Caminero — researcher profile on SciRah

Invite

H. Kunst — researcher profile on SciRah

F. Palmieri×10

Invite

F. Palmieri — researcher profile on SciRah

Invite

M. Payen — researcher profile on SciRah